AAAAAA
Results:
1-24
|
Results: 24
Authors:
Sondak, VK
Citation: Vk. Sondak, Adjuvant therapy for melanoma, CANCER J, 7, 2001, pp. S24-S27
Authors:
Sondak, VK
Chang, AE
Citation: Vk. Sondak et Ae. Chang, Treating colon cancer with a melanoma vaccine? Preposterous?, ANN SURG O, 8(5), 2001, pp. 386-388
Authors:
Johnson, TM
Yahanda, AM
Sondak, VK
Cimmino, V
Lowe, L
Citation: Tm. Johnson et al., Cutaneous melanoma: Role of lymphatic mapping and sentinel node biopsy, CURR P D-US, 13(2), 2001, pp. 119-122
Authors:
Kirkwood, JM
Ibrahim, JG
Sosman, JA
Sondak, VK
Agarwala, SS
Ernstoff, MS
Rao, U
Citation: Jm. Kirkwood et al., High-dose interferon alfa-2b significantly prolongs relapse-free and overall survival compared with the GM2-KLH/QS-21 vaccine in patients with resected stage IIB-III melanoma: Results of Intergroup trial E1694/S9512/C509801, J CL ONCOL, 19(9), 2001, pp. 2370-2380
Authors:
Whitehead, RP
Unger, JM
Flaherty, LE
Eckardt, JR
Taylor, SA
Didolkar, MS
Samlowski, W
Sondak, VK
Citation: Rp. Whitehead et al., Phase II trial of CI-980 in patients with disseminated malignant melanoma and no prior chemotherapy - A Southwest Oncology Group study, INV NEW DR, 19(3), 2001, pp. 239-243
Authors:
Rees, R
Sondak, VK
Citation: R. Rees et Vk. Sondak, Management of primary cutaneous melanoma of the head and neck: The University of Colorado experience and a review of the literature - Commentary, J SURG ONC, 77(3), 2001, pp. 186-187
Authors:
Unger, JM
Flaherty, LE
Liu, PY
Albain, KS
Sondak, VK
Citation: Jm. Unger et al., Gender and other survival predictors in patients with metastatic melanoma on southwest oncology group trials, CANCER, 91(6), 2001, pp. 1148-1155
Authors:
Sondak, VK
Flaherty, LE
Citation: Vk. Sondak et Le. Flaherty, Adjuvant high-dose interferon revisited, CANCER J, 6(3), 2000, pp. 132-134
Authors:
Brewer, GJ
Dick, RD
Grover, DK
LeClaire, V
Tseng, M
Wicha, M
Pienta, K
Redman, BG
Jahan, T
Sondak, VK
Strawderman, M
LeCarpentier, G
Merajver, SD
Citation: Gj. Brewer et al., Treatment of metastatic cancer with tetrathiomolybdate, an anticopper, antiangiogenic agent: Phase I study, CLIN CANC R, 6(1), 2000, pp. 1-10
Authors:
Sondak, VK
Citation: Vk. Sondak, Difficult situations in sarcoma - Issue 2, SURG ONCOL, 9(2), 2000, pp. 47-47
Authors:
Kirkwood, JM
Ibrahim, JG
Sondak, VK
Richards, J
Flaherty, LE
Ernstoff, MS
Smith, TJ
Rao, U
Steele, M
Blum, RH
Citation: Jm. Kirkwood et al., High- and low-dose interferon alfa-2b in high-risk melanoma: First analysis of Intergroup Trial E1690/S9111/C9190, J CL ONCOL, 18(12), 2000, pp. 2444-2458
Authors:
Gupta, AK
Cohan, RH
Francis, IR
Sondak, VK
Korobkin, M
Citation: Ak. Gupta et al., CT of recurrent retroperitoneal sarcomas, AM J ROENTG, 174(4), 2000, pp. 1025-1030
Authors:
Sondak, VK
Boddie, AW
Posner, MC
Sabel, MS
Citation: Vk. Sondak et al., Evolution of sentinel lymph node biopsy for melanoma at a National Cancer Institute - designated cancer center - Discussion, SURGERY, 128(4), 2000, pp. 562-563
Authors:
Lin, JY
Jin, XH
Page, C
Sondak, VK
Jiang, GH
Reynolds, RK
Citation: Jy. Lin et al., A modified p53 overcomes mdm2-mediated oncogenic transformation: A potential cancer therapeutic agent, CANCER RES, 60(20), 2000, pp. 5895-5901
Authors:
Sondak, VK
Margolin, KA
Citation: Vk. Sondak et Ka. Margolin, Melanoma and other cutaneous malignancies, SURGERY: BASIC SCIENCE AND CLINICAL EVIDENCE, 2000, pp. 1733-1752
Authors:
Sondak, VK
Liu, PY
Flaherty, LE
Fletcher, WS
Periman, P
Gandara, DR
Taylor, SA
Balcerzak, SP
Meyskens, FL
Citation: Vk. Sondak et al., A phase II evaluation of all-trans-retinoic acid plus interferon alfa-2a in stage IV melanoma: a Southwest Oncology Group Study, CA J SCI AM, 5(1), 1999, pp. 41-47
Authors:
Sondak, VK
Citation: Vk. Sondak, Surgical oncology, J AM COLL S, 188(2), 1999, pp. 178-183
Authors:
McMasters, KM
Sondak, VK
Lotze, MT
Ross, MI
Citation: Km. Mcmasters et al., Recent advances in melanoma staging and therapy, ANN SURG O, 6(5), 1999, pp. 467-475
Authors:
Durand-Zaleski, I
Roche, B
Buyse, M
Carlson, R
O'Connell, M
Rougier, P
Chang, AE
Sondak, VK
Kemeny, M
Allen-Mersh, T
Fagniez, PL
Le Bourgeois, JP
Piedbois, P
Citation: I. Durand-zaleski et al., Economic implications of hepatic arterial infusion versus intravenous chemotherapy or symptom palliation in the treatment of nonresectable colorectalliver metastases, CR R ONC H, 32(2), 1999, pp. 125-131
Authors:
Sondak, VK
Citation: Vk. Sondak, Difficult situations in sarcoma Issue 1, SURG ONCOL, 8(4), 1999, pp. 181-181
Authors:
Sondak, VK
Cimmino, VM
Lowe, LM
Dubay, DA
Johnson, TM
Citation: Vk. Sondak et al., Dermatofibrosarcoma protuberans: what is the best surgical approach?, SURG ONCOL, 8(4), 1999, pp. 183-189
Authors:
Galanis, E
Hersh, EM
Stopeck, AT
Gonzalez, R
Burch, P
Spier, C
Akporiaye, ET
Rinehart, JJ
Edmonson, J
Sobol, RE
Forscher, C
Sondak, VK
Lewis, BD
Unger, EC
O'Driscoll, M
Selk, L
Rubin, J
Citation: E. Galanis et al., Immunotherapy of advanced malignancy by direct gene transfer of an interleukin-2 DNA/DMRIE/DOPE lipid complex: Phase I/II experience, J CL ONCOL, 17(10), 1999, pp. 3313-3323
Authors:
Margolin, KA
Liu, PY
Unger, JM
Fletcher, WS
Flaherty, LE
Urba, WJ
Hersh, EM
Hutchins, LE
Sosman, JA
Smith, JW
Weiss, GR
Sondak, VK
Citation: Ka. Margolin et al., Phase II trial of biochemotherapy with interferon alpha, dacarbazine, cisplatin and tamoxifen in metastatic melanoma: a Southwest Oncology Group trial, J CANC RES, 125(5), 1999, pp. 292-296
Authors:
Flaherty, LE
Unger, JM
Liu, PY
Mertens, WC
Sondak, VK
Citation: Le. Flaherty et al., Metastatic melanoma from in intraocular primary tumors - Southwest Oncology Group experience in phase II advanced melanoma clinical trials, AM J CL ONC, 21(6), 1998, pp. 568-572
Risultati:
1-24
|